Detalles de la búsqueda
1.
Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
Int J Cancer
; 139(8): 1799-809, 2016 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27253354
2.
A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
Int J Cancer
; 134(11): 2547-59, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24243620
3.
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment.
Nat Commun
; 14(1): 4253, 2023 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474523
4.
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.
Oncoimmunology
; 5(4): e1119354, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27141401
5.
ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
J Natl Cancer Inst
; 108(5)2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26640245
Resultados
1 -
5
de 5
1
Próxima >
>>